New Approaches to Treating Challenging Subtypes of ALL in AYA Patients
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,Hematology
Link
https://link.springer.com/content/pdf/10.1007/s11899-020-00597-y.pdf
Reference88 articles.
1. • Siegel SE, Stock W, Johnson RH, Advani A, Muffly L, Douer D, et al. Pediatric-inspired treatment regimens for adolescents and young adults with Philadelphia chromosome-negative acute lymphoblastic leukemia: a review. JAMA Oncol. 2018;4(5):725–34. https://doi.org/10.1001/jamaoncol.2017.5305This review summarizes strong retrospective data supporting the use of pediatric inspired chemotherapy regimens in the treatment of AYA ALL.
2. •• DeAngelo DJ, Stevenson KE, Dahlberg SE, Silverman LB, Couban S, Supko JG, et al. Long-term outcome of a pediatric-inspired regimen used for adults aged 18-50 years with newly diagnosed acute lymphoblastic leukemia. Leukemia. 2015;29(3):526–34. https://doi.org/10.1038/leu.2014.229Prospective trial that shows improved survival with pediatric inspired chemotherapy regimens for AYA patients with newly diagnosed ALL.
3. •• Toft N, Birgens H, Abrahamsson J, Griskevicius L, Hallbook H, Heyman M, et al. Results of NOPHO ALL2008 treatment for patients aged 1-45 years with acute lymphoblastic leukemia. Leukemia. 2018;32(3):606–15. https://doi.org/10.1038/leu.2017.265Prospective trial that shows improved survival with pediatric inspired chemotherapy regimens for AYA patients with newly diagnosed ALL.
4. •• Stock W, Luger SM, Advani AS, Yin J, Harvey RC, Mullighan CG, et al. A pediatric regimen for older adolescents and young adults with acute lymphoblastic leukemia: results of CALGB 10403. Blood. 2019;133(14):1548–59. https://doi.org/10.1182/blood-2018-10-881961Prospective trial that shows improved survival with pediatric inspired chemotherapy regimens for AYA patients with newly diagnosed ALL.
5. Rizzari C, Putti MC, Colombini A, Casagranda S, Ferrari GM, Papayannidis C, et al. Rationale for a pediatric-inspired approach in the adolescent and young adult population with acute lymphoblastic leukemia, with a focus on asparaginase treatment. Hematol Rep. 2014;6(3):5554. https://doi.org/10.4081/hr.2014.5554.
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Long-Term Outcomes among Adolescent and Young Adult Survivors of Acute Leukemia: A Surveillance, Epidemiology, and End Results Analysis;Cancer Epidemiology, Biomarkers & Prevention;2022-05-13
2. Early T-Cell Precursor ALL and Beyond: Immature and Ambiguous Lineage T-ALL Subsets;Cancers;2022-04-08
3. The current approach and the treatment of adolescents and young adults with acute lymphoblastic leukemia;Medical review;2022
4. Pediatrik Vakalarda Philadelphia Benzeri Akut Lenfoblastik Lösemi;Güncel Pediatri;2021-04-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3